O Neil Global Advisors Inc. lifted its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) by 18.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,343 shares of the biopharmaceutical company’s stock after purchasing an additional 4,505 shares during the period. […]
Hancock Whitney Corp purchased a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 14,818 shares of the biopharmaceutical company’s stock, valued at approximately $275,000. Several other large investors have also recently […]
Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Rating) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Monday. Several other equities analysts also recently commented on CPRX. Cantor Fitzgerald increased their price objective on shares of Catalyst Pharmaceuticals from $22.00 to $25.00 in a research […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) insider Carmen Jeffrey Del sold 40,000 shares of the company’s stock in a transaction dated Wednesday, March 29th. The shares were sold at an average price of $16.70, for a total transaction of $668,000.00. Following the sale, the insider now owns 7,541 shares of the company’s stock, valued […]
Prospera Financial Services Inc reduced its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) by 13.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,804 shares of the biopharmaceutical company’s stock after selling 4,586 shares during the quarter. […]